276 related articles for article (PubMed ID: 11404475)
1. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP.
Czar MJ; Kersh EN; Mijares LA; Lanier G; Lewis J; Yap G; Chen A; Sher A; Duckett CS; Ahmed R; Schwartzberg PL
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7449-54. PubMed ID: 11404475
[TBL] [Abstract][Full Text] [Related]
2. SAP controls T cell responses to virus and terminal differentiation of TH2 cells.
Wu C; Nguyen KB; Pien GC; Wang N; Gullo C; Howie D; Sosa MR; Edwards MJ; Borrow P; Satoskar AR; Sharpe AH; Biron CA; Terhorst C
Nat Immunol; 2001 May; 2(5):410-4. PubMed ID: 11323694
[TBL] [Abstract][Full Text] [Related]
3. Hypogammaglobulinemia and exacerbated CD8 T-cell-mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease.
Crotty S; McCausland MM; Aubert RD; Wherry EJ; Ahmed R
Blood; 2006 Nov; 108(9):3085-93. PubMed ID: 16788096
[TBL] [Abstract][Full Text] [Related]
4. Mice deficient in the X-linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine gammaherpesvirus-68 and hypo-gammaglobulinemia.
Yin L; Al-Alem U; Liang J; Tong WM; Li C; Badiali M; Médard JJ; Sumegi J; Wang ZQ; Romeo G
J Med Virol; 2003 Nov; 71(3):446-55. PubMed ID: 12966553
[TBL] [Abstract][Full Text] [Related]
5. Molecular and immunological basis of X-linked lymphoproliferative disease.
Latour S; Veillette A
Immunol Rev; 2003 Apr; 192():212-24. PubMed ID: 12670406
[TBL] [Abstract][Full Text] [Related]
6. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase.
Aoukaty A; Tan R
J Biol Chem; 2002 Apr; 277(15):13331-7. PubMed ID: 11815622
[TBL] [Abstract][Full Text] [Related]
7. X-linked lymphoproliferative disease: a progressive immunodeficiency.
Morra M; Howie D; Grande MS; Sayos J; Wang N; Wu C; Engel P; Terhorst C
Annu Rev Immunol; 2001; 19():657-82. PubMed ID: 11244050
[TBL] [Abstract][Full Text] [Related]
8. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.
Shinozaki K; Kanegane H; Matsukura H; Sumazaki R; Tsuchida M; Makita M; Kimoto Y; Kanai R; Tsumura K; Kondoh T; Moriuchi H; Miyawaki T
Int Immunol; 2002 Oct; 14(10):1215-23. PubMed ID: 12356686
[TBL] [Abstract][Full Text] [Related]
9. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.
Sayos J; Wu C; Morra M; Wang N; Zhang X; Allen D; van Schaik S; Notarangelo L; Geha R; Roncarolo MG; Oettgen H; De Vries JE; Aversa G; Terhorst C
Nature; 1998 Oct; 395(6701):462-9. PubMed ID: 9774102
[TBL] [Abstract][Full Text] [Related]
10. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.
Sumegi J; Seemayer TA; Huang D; Davis JR; Morra M; Gross TG; Yin L; Romco G; Klein E; Terhorst C; Lanyi A
Leuk Lymphoma; 2002 Jun; 43(6):1189-201. PubMed ID: 12152986
[TBL] [Abstract][Full Text] [Related]
11. SLAM-associated protein deficiency causes imbalanced early signal transduction and blocks downstream activation in T cells from X-linked lymphoproliferative disease patients.
Sanzone S; Zeyda M; Saemann MD; Soncini M; Holter W; Fritsch G; Knapp W; Candotti F; Stulnig TM; Parolini O
J Biol Chem; 2003 Aug; 278(32):29593-9. PubMed ID: 12766168
[TBL] [Abstract][Full Text] [Related]
12. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
Tangye SG; Phillips JH; Lanier LL; Nichols KE
J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
[TBL] [Abstract][Full Text] [Related]
13. Regulation of NKT cell development by SAP, the protein defective in XLP.
Nichols KE; Hom J; Gong SY; Ganguly A; Ma CS; Cannons JL; Tangye SG; Schwartzberg PL; Koretzky GA; Stein PL
Nat Med; 2005 Mar; 11(3):340-5. PubMed ID: 15711562
[TBL] [Abstract][Full Text] [Related]
14. Genomic organization and characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease.
Wu C; Sayos J; Wang N; Howie D; Coyle A; Terhorst C
Immunogenetics; 2000 Aug; 51(10):805-15. PubMed ID: 10970095
[TBL] [Abstract][Full Text] [Related]
15. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
Sayós J; Nguyen KB; Wu C; Stepp SE; Howie D; Schatzle JD; Kumar V; Biron CA; Terhorst C
Int Immunol; 2000 Dec; 12(12):1749-57. PubMed ID: 11099315
[TBL] [Abstract][Full Text] [Related]
16. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.
Tangye SG; Nichols KE; Hare NJ; van de Weerdt BC
J Immunol; 2003 Sep; 171(5):2485-95. PubMed ID: 12928397
[TBL] [Abstract][Full Text] [Related]
17. The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production.
Howie D; Okamoto S; Rietdijk S; Clarke K; Wang N; Gullo C; Bruggeman JP; Manning S; Coyle AJ; Greenfield E; Kuchroo V; Terhorst C
Blood; 2002 Oct; 100(8):2899-907. PubMed ID: 12351401
[TBL] [Abstract][Full Text] [Related]
18. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
[TBL] [Abstract][Full Text] [Related]
19. Expression of signaling lymphocytic activation molecule-associated protein interrupts IFN-gamma production in human tuberculosis.
Pasquinelli V; Quiroga MF; Martínez GJ; Zorrilla LC; Musella RM; Bracco MM; Belmonte L; Malbrán A; Fainboim L; Sieling PA; García VE
J Immunol; 2004 Jan; 172(2):1177-85. PubMed ID: 14707094
[TBL] [Abstract][Full Text] [Related]
20. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease.
Sharifi R; Sinclair JC; Gilmour KC; Arkwright PD; Kinnon C; Thrasher AJ; Gaspar HB
Blood; 2004 May; 103(10):3821-7. PubMed ID: 14726378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]